// App-Quantinova.ai

BS5 : Senescent cardiomyocytes contribute to cardiac dysfunction following myocardial infarction

Researchers

Presenter

  • Rachael Redgrave

Principal Investigators

  • Emily Dookun

  • Laura Booth

  • Omowumi Folaranmi

  • Simon Tual-Chalot

  • Jason Gill

  • Andrew Owens

  • Ioakim Spyridopoulos

  • Joao Passos

  • Gavin Richardson

Medical Centers

  • Newcastle University, Biosciences Institute Newcastle University Newcastle upon Tyne, TWR NE BZ United Kingdom, UK

  • Department of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, MN, USA

  • Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK

  • Biosciences Institute, Newcastle University, Newcastle upon Tyne, UK

Locations

  • United Kingdom

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Genetic Disorder

Disease

  • Hypertrophic cardiomyopathy

  • Myocardial infarction

  • Congestive heart failure

Biomarkers

  • Cyclin Dependent Kinase Inhibitor 2A

Drug/Treatment

  • Navitoclax

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final